{"id":22059,"date":"2020-06-14T11:57:58","date_gmt":"2020-06-14T11:57:58","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=22059"},"modified":"2020-06-14T11:57:58","modified_gmt":"2020-06-14T11:57:58","slug":"viiv-healthcare-announces-us-fda-approval-of-the-first-ever-dispersible-tablet-formulation-of-dolutegravir-tivicay-pd-a-once-daily-treatment-for-children-living-with-hiv","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2020\/06\/14\/viiv-healthcare-announces-us-fda-approval-of-the-first-ever-dispersible-tablet-formulation-of-dolutegravir-tivicay-pd-a-once-daily-treatment-for-children-living-with-hiv\/","title":{"rendered":"ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-22060\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_-300x169.jpg 300w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_-600x337.jpg 600w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_-500x282.jpg 500w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><span style=\"display: inline !important; float: none; background-color: #fefefe; color: #444444; font-family: 'Helvetica Neue',Helvetica,Arial,'Lucida Grande',sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders<\/span> <a href=\"https:\/\/www.businesswire.com\/news\/home\/20200612005548\/en\/ViiV-Healthcare-announces-FDA-approval-first-ever-dispersible\/?feedref=JjAwJuNHiystnCoBq_hl-fqXyBvmekC3Xq1G1wQ7hjMFbZM1ntlKeK-8bUzJqFSVSfe41V1BKA-b6v2ZVrSSNs-dUYKiDvY7XniNSqv88QcY1Ge_vf9QIMZ4alzIf_0HlyE0C4hZhHVlTvKnn0d0vQ==\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders Read More<\/p>\n","protected":false},"author":1,"featured_media":22060,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-22059","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/ViiV-Healthcare_.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=22059"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22059\/revisions"}],"predecessor-version":[{"id":22061,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22059\/revisions\/22061"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/22060"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=22059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=22059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=22059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}